James Ede-Golightly - 14 Dec 2025 Form 3 Insider Report for Silence Therapeutics plc (SLN)

Reporting relationship
Director
Issuer ticker
SLN
Reported as of
14 Dec 2025
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
3
Accepted by SEC
22 Dec 2025, 18:02:31 UTC
Prior SEC filing
06 Jan 2025
Next SEC filing
22 Dec 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Rhonda Hellums, Attorney-in-Fact

Key filing fact

James Ede-Golightly filed Form 3 for Silence Therapeutics plc (SLN) on 22 Dec 2025.

Key facts

  • This page summarizes James Ede-Golightly's Form 3 filing for Silence Therapeutics plc (SLN).
  • 0 reported transactions and 4 derivative rows are listed below.
  • Accepted by SEC: 22 Dec 2025, 18:02.

Change

  • Previous filing in this sequence was filed on 06 Jan 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002048873 Primary reporting owner

Ede-Golightly James

Relationship
Director
Address
C/O SILENCE THERAPEUTICS PLC, 12 HAMMERSMITH GROVE, LONDON, UNITED KINGDOM
Signature
/s/ Rhonda Hellums, Attorney-in-Fact
Signature date
22 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SLN holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
15,000
Date
14 Dec 2025
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SLN holding Derivative

Share Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
14 Dec 2025
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
48,000
Exercise price
$7.87
Footnotes
F1
SLN holding Derivative

Share Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
14 Dec 2025
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
27,999
Exercise price
$5.13
Footnotes
F1
SLN holding Derivative

Share Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
14 Dec 2025
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
22,668
Exercise price
$5.90
Footnotes
F1
SLN holding Derivative

Share Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
14 Dec 2025
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
6,666
Exercise price
$2.40
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Immediately exercisable.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .